Guggul and cholesterol

What 4 graded rows on guggul agree on for cholesterol, and where they differ. Counted side by side, never averaged.

What the rows agree on

Each block and row is one graded row from the Guggul page, with its PubMed record.

Your question

Supplement

Guggul and cholesterol

4 rows · 607 people

Split. 1 row found an improvement, 1 found no difference, 1 found a worse outcome and 1 had mixed results.

No difference, mixed or worse
Improved
Each block is one evidence row, sized by how many people it enrolled, with its grade inside. Red: a worse outcome. Outlined: mixed results.
  • Grade C× 3
  • Grade D× 1
Rows
4
Trials
10
People
607
Pooled reviews may count some twice

Where they differ

From the rows
Trial sizeStudy design

The best-graded row, grade C, is a meta-analysis of 380 people (2021) and found an improvement.

The row that found an improvement was larger: 380 people, against 90 people for the row that found no difference.

The row that found an improvement is a pooled review of several trials; the row that found no difference is a single study.

1 row with mixed results is left out of this comparison.

The rows

1 improved · 1 no difference · 1 worse · 1 mixed
  1. Grade CTotal and LDL cholesterol (Ayurvedic trials) · Improved

    Meta-analysis, 7 studies · n 380 · 2021 · People with high cholesterol in 7 placebo-controlled RCTs of guggulu (8 trial arms), from a review of garlic, guggulu and black cumin

    Varied by trial · Average 12 weeks

    Guggulu lowered total cholesterol by 16.78 mg/dL and LDL by 18.78 mg/dL versus placebo; in 5 trials (264 people) HDL rose 2.19 mg/dL, and triglycerides did not change significantly.

    Row on the Guggul page · PubMed 34071454 (opens PubMed)

  2. Grade CTotal and LDL cholesterol with guggulu plus triphala · No difference

    RCT · n 90 · 2021 · Adults at low-to-moderate cardiovascular risk with high cholesterol (Brescia, Italy)

    Three times daily (product dose) · 3 months

    LDL fell 4.8% with the blend and 4.9% with placebo, with no difference; BMI and waist did not change. 2 on the blend developed a hypersensitivity rash.

    Row on the Guggul page · PubMed 33242870 (opens PubMed)

  3. Grade CLDL cholesterol in adults with high cholesterol · Worse

    RCT · n 103 · 2003 · Healthy adults with hypercholesterolaemia eating a Western diet (Philadelphia, USA)

    1,000 mg or 2,000 mg three times daily · 8 weeks

    LDL rose 4% (standard dose) and 5% (high dose) vs a 5% fall on placebo (P = .01 and .006); total cholesterol, HDL and triglycerides did not change. 6 users had a hypersensitivity rash.

    Row on the Guggul page · PubMed 12915429 (opens PubMed)

  4. Grade DTotal cholesterol in moderately high cholesterol · Mixed

    RCT · n 34 · 2009 · Adults aged 27-70 with moderately raised cholesterol in Norwegian general practice (43 randomised)

    2,160 mg/day · 12 weeks

    Total cholesterol and HDL fell versus placebo, but LDL, triglycerides and the total/HDL ratio did not change. 10 guggul users vs 4 on placebo reported side effects, including possible thyroid problems (2) and a generalised rash (1).

    Row on the Guggul page · PubMed 19114224 (opens PubMed)

Educational only. Not medical advice. Some links earn us a commission: kymatahealth.com/affiliate-disclosure.